Convergence of Canonical and Non-Canonical Wnt Signal: Differential Kat3 Coactivator Usage

Author(s): Keane K.Y. Lai*, Cu Nguyen, Kyung-Soon Lee, Albert Lee, David P. Lin, Jia-Ling Teo, Michael Kahn*.

Journal Name: Current Molecular Pharmacology

Volume 12 , Issue 3 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Background: The ancient and highly evolutionarily conserved Wnt signaling pathway is critical in nearly all tissues and organs for an organism to develop normally from embryo through adult. Wnt signaling is generally parsed into “canonical” or Wnt-β-catenin-dependent or “non-canonical” β-catenin-independent signaling. Even though designating Wnt signaling as either canonical or noncanonical allows for easier conceptual discourse about this signaling pathway, in fact canonical and non-canonical Wnt crosstalk regulates complex nonlinear networks.

Objective: In this perspective, we discuss the integration of canonical and non-canonical Wnt signaling via differential Kat3 (CBP and p300) coactivator usage, thereby regulating and coordinating gene expression programs associated with both proliferation and cellular differentiation and morphogenesis.

Methods: Pharmacologic inhibitors, cell culture, real-time PCR, chromatin immunoprecipitation, protein immunoprecipitation, Western blotting, reporter-luciferase, protein purification, site-directed mutagenesis, in vitro phosphorylation and binding assays, and immunofluorescence were utilized.

Conclusion: Coordinated integration between both canonical and non-canonical Wnt pathways appears to be crucial not only in the control of fundamental morphologic processes but also in the regulation of normal as well as pathologic events. Such integration between both canonical and non-canonical Wnt signaling is presumably effected via reversible phosphorylation mechanism (e.g., protein kinase C) to regulate differential β -catenin/Kat3 coactivator usage in order to coordinate proliferation with differentiation and adhesion.

Keywords: Wnt, canonical, non-canonical, CBP, p300, Kat3 coactivator.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2019
Page: [167 - 183]
Pages: 17
DOI: 10.2174/1874467212666190304121131

Article Metrics

PDF: 14